Control of left ventricular massby moxonidine involves reduced DNA synthesis and enhanced DNA fragmentation - Paquette, PA; Duguay, D; El-Ayoubi, R; Menaouar, A; Danalache, B; Gutkowska, J (Br J Pharmacol., 2008)
et al.